Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             117 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine when used in combination with meglumine antimoniate for the treatment of cutaneous leishmaniasis Nascimento, Evaldo
2010
28 Supplement 5 p. 6581-6587
7 p.
artikel
2 A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine when used in combination with sodium stibogluconate for the treatment of mucosal leishmaniasis Llanos-Cuentas, Alejandro
2010
28 Supplement 5 p. 7427-7435
9 p.
artikel
3 A cost–benefit analysis of blood donor vaccination as an alternative to additional DNA testing for reducing transfusion transmission of hepatitis B virus Fischinger, J.M.
2010
28 Supplement 5 p. 7797-7802
6 p.
artikel
4 A cost–effectiveness analysis of Japanese encephalitis vaccine in Cambodia Touch, Sok
2010
28 Supplement 5 p. 4593-4599
7 p.
artikel
5 A decline in varicella but an uncertain impact on zoster following varicella vaccination in Victoria, Australia Carville, Kylie S.
2010
28 Supplement 5 p. 2532-2538
7 p.
artikel
6 Adult immunization services: Steps have to be done Huot, Caroline
2010
28 Supplement 5 p. 1177-1180
4 p.
artikel
7 Age-related efficacy of Shigella O-specific polysaccharide conjugates in 1–4-year-old Israeli children Passwell, Justen H.
2010
28 Supplement 5 p. 2231-2235
artikel
8 A new murine model for testing vaccines against genital Chlamydia trachomatis infections in males Pal, Sukumar
2010
28 Supplement 5 p. 7606-7612
7 p.
artikel
9 A novel triple adjuvant formulation promotes strong, Th1-biased immune responses and significant antigen retention at the site of injection Wilson, Heather L.
2010
28 Supplement 5 p. 8288-8299
12 p.
artikel
10 Antibody persistence six years after two doses of combined hepatitis A and B vaccine Burgess, Margaret A.
2010
28 Supplement 5 p. 2222-2226
artikel
11 A preliminary study of chemo- and cytokine responses in rabies vaccine recipients of intradermal and intramuscular regimens Saraya, Abhinbhen
2010
28 Supplement 5 p. 4553-4557
5 p.
artikel
12 A 3-year follow-up of antibody response in HIV-infected children with immune recovery vaccinated with inactivated Japanese encephalitis vaccine Puthanakit, Thanyawee
2010
28 Supplement 5 p. 5900-5902
3 p.
artikel
13 Carbohydrate moieties as vaccine candidates: Meeting summary Lucas, A.H.
2010
28 Supplement 5 p. 1121-1131
11 p.
artikel
14 CD8+ gamma-delta TCR+ and CD4+ T cells produce IFN-γ at 5–7 days after yellow fever vaccination in Indian rhesus macaques, before the induction of classical antigen-specific T cell responses Neves, Patrícia C.C.
2010
28 Supplement 5 p. 8183-8188
6 p.
artikel
15 Changing epidemiology of invasive Haemophilus influenzae in Ontario, Canada: Evidence for herd effects and strain replacement due to Hib vaccination Adam, H.J.
2010
28 Supplement 5 p. 4073-4078
6 p.
artikel
16 Colostral antibody protection and interference with immunity in lambs born from sheep vaccinated with an inactivated Bluetongue serotype 8 vaccine Oura, C.A.L.
2010
28 Supplement 5 p. 2749-2753
5 p.
artikel
17 Combined vaccination against IL-5 and eotaxin blocks eosinophilia in mice Zou, Yu
2010
28 Supplement 5 p. 3192-3200
9 p.
artikel
18 Comparability of antibody response to a booster dose of 7-valent pneumococcal conjugate vaccine in infants primed with either 2 or 3 doses Rodenburg, Gerwin D.
2010
28 Supplement 5 p. 1391-1396
6 p.
artikel
19 Comparison of T cell immune responses induced by vectored HIV vaccines in non-human primates and humans Bett, Andrew J.
2010
28 Supplement 5 p. 7881-7889
9 p.
artikel
20 Comparison of the safety and immunogenicity of an investigational and a licensed quadrivalent meningococcal conjugate vaccine in children 2–10 years of age Halperin, Scott A.
2010
28 Supplement 5 p. 7865-7872
8 p.
artikel
21 Complex cytokine profiles induced by BCG vaccination in UK infants Lalor, Maeve K.
2010
28 Supplement 5 p. 1635-1641
7 p.
artikel
22 Construction and immunogenicity of replication-competent adenovirus 5 host range mutant recombinants expressing HIV-1 gp160 of SF162 and TV1 strains Hidajat, Rachmat
2010
28 Supplement 5 p. 3963-3971
9 p.
artikel
23 Control of Salmonella Enteritidis and Salmonella Gallinarum in birds by using live vaccine candidate containing attenuated Salmonella Gallinarum mutant strain Penha Filho, Rafael Antonio Casarin
2010
28 Supplement 5 p. 2853-2859
7 p.
artikel
24 Control of Streptococcus pneumoniae serotype 5 epidemic of severe pneumonia among young army recruits by mass antibiotic treatment and vaccination Balicer, Ran D.
2010
28 Supplement 5 p. 5591-5596
6 p.
artikel
25 Corrigendum to “Molecular epidemiology of G9 rotavirus strains in children with diarrhoea hospitalized in Mainland China from January 2006 to December 2007” [Vaccine 27 (Suppl. 5) (2009) 40–45] Li, Dan-Di
2010
28 Supplement 5 p. 3506-
1 p.
artikel
26 Corrigendum to “The member of the cyclic di-nucleotide family bis-(3′,5′)-cyclic dimeric inosine monophosphate exerts potent activity as mucosal adjuvant” [Vaccine 28 (2010) 2249–2258] Libanova, Rimma
2010
28 Supplement 5 p. 3625-
1 p.
artikel
27 Decreased antibody titers and booster responses in tick-borne encephalitis vaccinees aged 50–90 years Weinberger, Birgit
2010
28 Supplement 5 p. 3511-3515
5 p.
artikel
28 Dendritic cell vaccine in addition to FOLFIRI regimen improve antitumor effects through the inhibition of immunosuppressive cells in murine colorectal cancer model Kim, Hye-Sung
2010
28 Supplement 5 p. 7787-7796
10 p.
artikel
29 Detoxified Haemophilus ducreyi cytolethal distending toxin and induction of toxin specific antibodies in the genital tract Lundqvist, Annika
2010
28 Supplement 5 p. 5768-5773
6 p.
artikel
30 Development of a nasal adenovirus-based vaccine: Effect of concentration and formulation on adenovirus stability and infectious titer during actuation from two delivery devices Renteria, Sandra S.
2010
28 Supplement 5 p. 2137-2148
12 p.
artikel
31 Development of a novel viral DNA vaccine against human papillomavirus: AcHERV-HP16L1 Lee, Hee-Jung
2010
28 Supplement 5 p. 1613-1619
7 p.
artikel
32 Dissection and localization of the immunostimulating domain of Edwardsiella tarda FliC Jiao, Xu-dong
2010
28 Supplement 5 p. 5635-5640
6 p.
artikel
33 DNA vaccine against human papillomavirus type 16: Modifications of the E6 oncogene Poláková, Ingrid
2010
28 Supplement 5 p. 1506-1513
8 p.
artikel
34 Dynamic model of rotavirus transmission and the impact of rotavirus vaccination in Kyrgyzstan de Blasio, Birgitte Freiesleben
2010
28 Supplement 5 p. 7923-7932
10 p.
artikel
35 Editorial Board 2010
28 Supplement 5 p. CO2
artikel
36 Editorial Board 2010
28 Supplement 5 p. CO2-
1 p.
artikel
37 Effects of astragalus polysaccharides on immunologic function of erythrocyte in chickens infected with infectious bursa disease virus Jiang, Junbing
2010
28 Supplement 5 p. 5614-5616
3 p.
artikel
38 Enterovirus 71 virus-like particle vaccine: Improved production conditions for enhanced yield Chung, Cheng-Yu
2010
28 Supplement 5 p. 6951-6957
7 p.
artikel
39 Epitopes of Mycobacterium avium ssp. paratuberculosis 70kDa heat-shock protein activate bovine helper T cells in outbred cattle Hoek, Aad
2010
28 Supplement 5 p. 5910-5919
10 p.
artikel
40 Evaluation of the efficacy and safety of the Rift Valley Fever Clone 13 vaccine in sheep Dungu, Baptiste
2010
28 Supplement 5 p. 4581-4587
7 p.
artikel
41 Evaluation of the safety and immunogenicity of Plasmodium falciparum apical membrane antigen 1, merozoite surface protein 1 or RTS,S vaccines with adjuvant system AS02A administered alone or concurrently in rhesus monkeys Pichyangkul, S.
2009
28 Supplement 5 p. 452-462
11 p.
artikel
42 Evaluation of yellow fever virus 17D strain as a new vector for HIV-1 vaccine development Franco, David
2010
28 Supplement 5 p. 5676-5685
10 p.
artikel
43 Evidence of Chlamydophila abortus vaccine strain 1B as a possible cause of ovine enzootic abortion Wheelhouse, Nicholas
2010
28 Supplement 5 p. 5657-5663
7 p.
artikel
44 Expanding immunization coverage in rural India: A review of evidence for the role of community health workers Patel, Amit R.
2010
28 Supplement 5 p. 604-613
10 p.
artikel
45 Feasibility of single-shot H5N1 influenza vaccine in ferrets, macaques and rabbits Heldens, J.G.M.
2010
28 Supplement 5 p. 8125-8131
7 p.
artikel
46 Flow cytometric assessment of chicken T cell-mediated immune responses after Newcastle disease virus vaccination and challenge Dalgaard, T.S.
2010
28 Supplement 5 p. 4506-4514
9 p.
artikel
47 GMP-grade pneumococcal whole-cell vaccine injected subcutaneously protects mice from nasopharyngeal colonization and fatal aspiration-sepsis Lu, Ying-Jie
2010
28 Supplement 5 p. 7468-7475
8 p.
artikel
48 Hepatitis A and travel amongst Nova Scotia postsecondary students: Evidence for a targeted vs. universal immunization strategy Matheson, Katherine
2010
28 Supplement 5 p. 8105-8111
7 p.
artikel
49 Heterologous HIV-based lentiviral/adenoviral vectors immunizations result in enhanced HIV-specific immunity Asefa, Benyam
2010
28 Supplement 5 p. 3617-3624
8 p.
artikel
50 High rates of serological response to a modified hepatitis B vaccination schedule in HIV-infected adults subjects Potsch, D.V.
2010
28 Supplement 5 p. 1447-1450
4 p.
artikel
51 Huge impact of assumptions on indirect effects on the cost-effectiveness of routine infant vaccination with 7-valent conjugate vaccine (Prevnar®) Rozenbaum, Mark H.
2010
28 Supplement 5 p. 2367-2369
3 p.
artikel
52 Immune response to the 23-valent polysaccharide pneumococcal vaccine after the 7-valent conjugate vaccine in allogeneic stem cell transplant recipients: Results from the EBMT IDWP01 trial Cordonnier, Catherine
2010
28 Supplement 5 p. 2730-2734
5 p.
artikel
53 Immunogenicity and safety of a monovalent vaccine for the 2009 pandemic influenza virus A (H1N1) in children and adolescents Lu, Chun-Yi
2010
28 Supplement 5 p. 5864-5870
7 p.
artikel
54 Immunogenicity and safety of the human rotavirus vaccine Rotarix™ co-administered with routine infant vaccines following the vaccination schedules in Europe Vesikari, Timo
2010
28 Supplement 5 p. 5272-5279
8 p.
artikel
55 Immunogenicity and thermal stability of a combined vaccine against Haemophilus influenzae type b and Neisseria meningitidis serogroup C diseases Saydam, Manolya
2010
28 Supplement 5 p. 6228-6234
7 p.
artikel
56 Impact of influenza vaccination of schoolchildren on medical outcomes among all residents of Maryland King Jr., James C.
2010
28 Supplement 5 p. 7737-7742
6 p.
artikel
57 Incidence of dog bite and anti-rabies vaccine utilization in the, University of Benin Teaching Hospital, Benin City, Nigeria: A 12-year assessment Aghahowa, S.E.
2010
28 Supplement 5 p. 4847-4850
4 p.
artikel
58 Indirect effect of conjugate pneumococcal vaccination in a 2+1 dose schedule Vestrheim, Didrik F.
2010
28 Supplement 5 p. 2214-2221
artikel
59 Influenza antigen-sparing by immune stimulation with Gram-positive enhancer matrix (GEM) particles Saluja, V.
2010
28 Supplement 5 p. 7963-7969
7 p.
artikel
60 International epidemiology of human pre-existing adenovirus (Ad) type-5, type-6, type-26 and type-36 neutralizing antibodies: Correlates of high Ad5 titers and implications for potential HIV vaccine trials Mast, T. Christopher
2010
28 Supplement 5 p. 950-957
8 p.
artikel
61 Intranasal immunization with vaccine vector Streptococcus gordonii elicits primed CD4+ and CD8+ T cells in the genital and intestinal tracts Ciabattini, Annalisa
2010
28 Supplement 5 p. 1226-1233
8 p.
artikel
62 Investigation on a pertussis outbreak in a military school: Risk factors and approach to vaccine efficacy Berger, F.
2010
28 Supplement 5 p. 5147-5152
6 p.
artikel
63 In vivo cross-protection to African horse sickness Serotypes 5 and 9 after vaccination with Serotypes 8 and 6 von Teichman, Beate F.
2010
28 Supplement 5 p. 6505-6517
13 p.
artikel
64 Isolation and analysis of the vaccine potential of an attenuated Edwardsiella tarda strain Sun, Yun
2010
28 Supplement 5 p. 6344-6350
7 p.
artikel
65 Longevity of protection in cattle following immunisation with emergency FMD A22 serotype vaccine from the UK strategic reserve Cox, Sarah J.
2010
28 Supplement 5 p. 2318-2322
5 p.
artikel
66 Long-term protection provided by hepatitis B vaccine and need for booster dose: A meta-analysis Poorolajal, Jalal
2010
28 Supplement 5 p. 623-631
9 p.
artikel
67 Long-term (5-year) antibody persistence following two- and three-dose regimens of a combined hepatitis A and B vaccine in children aged 1–11 years Marshall, Helen
2010
28 Supplement 5 p. 4411-4415
5 p.
artikel
68 Low serum serotype-specific pneumococcal antibody concentrations in young children with Haemophilus influenzae serotype b (Hib) vaccine failure Ladhani, Shamez
2010
28 Supplement 5 p. 4440-4444
5 p.
artikel
69 MCV vaccination in the presence of vaccine-associated Guillain–Barré Syndrome risk: A decision analysis approach Cho, Bo-Hyun
2010
28 Supplement 5 p. 817-822
6 p.
artikel
70 Measles outbreak in Tanzania, 2006–2007 Goodson, James L.
2010
28 Supplement 5 p. 5979-5985
7 p.
artikel
71 Modeling the impact of one- and two-dose varicella vaccination on the epidemiology of varicella and zoster Brisson, Marc
2010
28 Supplement 5 p. 3385-3397
13 p.
artikel
72 Omission bias and vaccine rejection by parents of healthy children: Implications for the influenza A/H1N1 vaccination programme Brown, Katrina F.
2010
28 Supplement 5 p. 4181-4185
5 p.
artikel
73 Oral vaccination with Ts87 DNA vaccine delivered by attenuated Salmonella typhimurium elicits a protective immune response against Trichinella spiralis larval challenge Yang, Yaping
2010
28 Supplement 5 p. 2735-2742
8 p.
artikel
74 Ovine atadenovirus, a novel and highly immunogenic vector in prime-boost studies of a candidate HIV-1 vaccine Bridgeman, Anne
2009
28 Supplement 5 p. 474-483
10 p.
artikel
75 Paclitaxel acts as an adjuvant to promote both Th1 and Th2 immune responses induced by ovalbumin in mice Yuan, Lin
2010
28 Supplement 5 p. 4402-4410
9 p.
artikel
76 Peak frequencies of circulating human influenza-specific antibody secreting cells correlate with serum antibody response after immunization Halliley, Jessica L.
2010
28 Supplement 5 p. 3582-3587
6 p.
artikel
77 Persistence of antibodies and immune memory to hepatitis B vaccine 20 years after infant vaccination in Thailand Poovorawan, Yong
2010
28 Supplement 5 p. 730-736
7 p.
artikel
78 Pharmacoeconomic evaluation of 10- and 13-valent pneumococcal conjugate vaccines Chuck, Anderson W.
2010
28 Supplement 5 p. 5485-5490
6 p.
artikel
79 Phase 1 safety and immunogenicity trial of the Plasmodium falciparum blood-stage malaria vaccine AMA1-C1/ISA 720 in Australian adults Pierce, Mark A.
2010
28 Supplement 5 p. 2236-2242
artikel
80 Post-licensure comparison of the safety profile of diphtheria/tetanus/whole cell pertussis/haemophilus influenza type b vaccine and a 5-in-1 diphtheria/tetanus/acellular pertussis/haemophilus influenza type b/polio vaccine in the United Kingdom Andrews, Nick
2010
28 Supplement 5 p. 7215-7220
6 p.
artikel
81 Potency against enterotoxemia of a recombinant Clostridium perfringens type D epsilon toxoid in ruminants Lobato, Francisco C.F.
2010
28 Supplement 5 p. 6125-6127
3 p.
artikel
82 Potent immune responses and in vitro pro-inflammatory cytokine suppression by a novel adenovirus vaccine vector based on rare human serotype 28 Kahl, Christoph A.
2010
28 Supplement 5 p. 5691-5702
12 p.
artikel
83 Predictors of universal influenza vaccination uptake in grades 1 and 2 Toronto school children: Effective vaccination strategies should not end with at risk children Foty, Richard G.
2010
28 Supplement 5 p. 6518-6522
5 p.
artikel
84 Questionnaire survey about the motives of commercial livestock farmers and hobby holders to vaccinate their animals against Bluetongue virus serotype 8 in 2008–2009 in the Netherlands Elbers, A.R.W.
2010
28 Supplement 5 p. 2473-2481
9 p.
artikel
85 Randomized double-blind controlled Phase I/IIa trial to assess the efficacy of malaria vaccine PfCS102 to protect against challenge with P. falciparum Genton, Blaise
2010
28 Supplement 5 p. 6573-6580
8 p.
artikel
86 Recombinant Leishmania tarentolae expressing the A2 virulence gene as a novel candidate vaccine against visceral leishmaniasis Mizbani, Amir
2009
28 Supplement 5 p. 53-62
10 p.
artikel
87 Recombinant Liver Stage Antigen-1 (LSA-1) formulated with AS01 or AS02 is safe, elicits high titer antibody and induces IFN-γ/IL-2 CD4+ T cells but does not protect against experimental Plasmodium falciparum infection Cummings, James F.
2010
28 Supplement 5 p. 5135-5144
10 p.
artikel
88 Repeated inoculation of killed Leishmania major induces durable immune response that protects mice against virulent challenge Okwor, Ifeoma
2010
28 Supplement 5 p. 5451-5457
7 p.
artikel
89 Rotavirus incidence and genotype distribution before and after national rotavirus vaccine introduction in Belgium Zeller, Mark
2010
28 Supplement 5 p. 7507-7513
7 p.
artikel
90 Safety and immunogenicity of a diphtheria, tetanus, acellular pertussis and Haemophilus influenzae Type b combination vaccine compared with separate administration of licensed equivalent vaccines in Chinese infants and toddlers for primary and booster immunization Li, Guifan
2010
28 Supplement 5 p. 4215-4223
9 p.
artikel
91 Safety and immunogenicity of adjuvanted inactivated split-virion and whole-virion influenza A (H5N1) vaccines in children: A phase I–II randomized trial Wu, Jiang
2010
28 Supplement 5 p. 6221-6227
7 p.
artikel
92 Safety and immunogenicity of single dose of tetanus–diphtheria (Td) vaccine among non/partially immune children against diphtheria and/or tetanus, Hyderabad, India, 2007 Bitragunta, Sailaja
2010
28 Supplement 5 p. 5934-5938
5 p.
artikel
93 Safety and immunogenicity of whole-virus, alum-adjuvanted whole-virus, virosomal, and whole-virus intradermal influenza A/H9N2 vaccine formulations Nicholson, Karl G.
2009
28 Supplement 5 p. 171-178
8 p.
artikel
94 Safety of MF59-adjuvanted versus non-adjuvanted influenza vaccines in children and adolescents: An integrated analysis Black, Steven
2010
28 Supplement 5 p. 7331-7336
6 p.
artikel
95 Safety, tolerability, and immunogenicity of zoster vaccine in subjects with a history of herpes zoster Mills, Richard
2010
28 Supplement 5 p. 4204-4209
6 p.
artikel
96 Serotype coverage of pneumococcal conjugate vaccine and drug susceptibility of Streptococcus pneumoniae isolated from invasive or non-invasive diseases in central Thailand, 2006–2009 Srifeungfung, Somporn
2010
28 Supplement 5 p. 3440-3444
5 p.
artikel
97 Serotype distribution of invasive pneumococcal disease during the first 60 days of life Imöhl, Matthias
2010
28 Supplement 5 p. 4758-4762
5 p.
artikel
98 Serum anti-toxin B antibody correlates with protection from recurrent Clostridium difficile infection (CDI) Leav, Brett A.
2010
28 Supplement 5 p. 965-969
5 p.
artikel
99 Single versus multi-dose vaccine vials: An economic computational model Lee, Bruce Y.
2010
28 Supplement 5 p. 5292-5300
9 p.
artikel
100 Socio-demographic and health-related predictors of uptake of first MMR immunisation in the Lifeways Cohort Study Jessop, L.J.
2010
28 Supplement 5 p. 6338-6343
6 p.
artikel
101 Study on the efficacy of Leptospira vaccines developed from serovars isolated from Trinidad and comparison with commercial vaccines using a hamster model Suepaul, S.M.
2010
28 Supplement 5 p. 5421-5426
6 p.
artikel
102 The Australian model of immunization advice and vaccine funding Nolan, Terry M.
2010
28 Supplement 5 p. A76-A83
nvt p.
artikel
103 The effect of anti-TNF treatment on the immunogenicity and safety of the 7-valent conjugate pneumococcal vaccine in children with juvenile idiopathic arthritis Farmaki, Evangelia
2010
28 Supplement 5 p. 5109-5113
5 p.
artikel
104 The epidemiology of chickenpox in UK 5-year olds: An analysis to inform vaccine policy Manikkavasagan, Gayatri
2010
28 Supplement 5 p. 7699-7705
7 p.
artikel
105 The health care burden and societal impact of acute otitis media in seven European countries: Results of an Internet survey Wolleswinkel-van den Bosch, Judith H.
2010
28 Supplement 5 p. G39-G52
nvt p.
artikel
106 The impact of antigenic drift of influenza A virus on human herd immunity: Sero-epidemiological study of H1N1 in healthy Thai population in 2009 Kanai, Yuta
2010
28 Supplement 5 p. 5437-5444
8 p.
artikel
107 The member of the cyclic di-nucleotide family bis-(3′, 5′)-cyclic dimeric inosine monophosphate exerts potent activity as mucosal adjuvant Libanova, Rimma
2010
28 Supplement 5 p. 2249-2258
artikel
108 The need for quadrivalent vaccine against seasonal influenza Belshe, Robert B.
2010
28 Supplement 5 p. D45-D53
nvt p.
artikel
109 The potential of 3′,5′-cyclic diguanylic acid (c-di-GMP) as an effective vaccine adjuvant Chen, Wangxue
2010
28 Supplement 5 p. 3080-3085
6 p.
artikel
110 The preventive phase I trial with the HIV-1 Tat-based vaccine Ensoli, Barbara
2009
28 Supplement 5 p. 371-378
8 p.
artikel
111 Th2-polarisation of cellular immune memory to neonatal pertussis vaccination White, Olivia J.
2010
28 Supplement 5 p. 2648-2652
5 p.
artikel
112 TLR8 agonists stimulate newly recruited monocyte-derived cells into potent APCs that enhance HBsAg immunogenicity Du, Jun
2010
28 Supplement 5 p. 6273-6281
9 p.
artikel
113 Universal rubella vaccination programme and maternal rubella immune status: A tale of two systems Lao, Terence T.
2010
28 Supplement 5 p. 2227-2230
artikel
114 Vaccination as infection control: A pilot study to determine the impact of Staphylococcus aureus vaccination on nasal carriage Creech II, C. Buddy
2009
28 Supplement 5 p. 256-260
5 p.
artikel
115 Vaccination of commercial broiler chicks against avian metapneumovirus infection: a comparison of drinking-water, spray and oculo-oral delivery methods Ganapathy, Kannan
2010
28 Supplement 5 p. 3944-3948
5 p.
artikel
116 Vaccination of grouper broodfish (Epinephelus tukula) reduces the risk of vertical transmission by nervous necrosis virus Kai, Yu-Hsuan
2010
28 Supplement 5 p. 996-1001
6 p.
artikel
117 Vaxfectin® enhances both antibody and in vitro T cell responses to each component of a 5-gene Plasmodium falciparum plasmid DNA vaccine mixture administered at low doses Sedegah, Martha
2010
28 Supplement 5 p. 3055-3065
11 p.
artikel
                             117 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland